Signaling and ligand interaction of ILT7: Receptor-mediated regulatory mechanisms for plasmacytoid dendritic cells

Immunological Reviews

Volumn 234, Issue 1, 2010, Pages 163-176

  Cao, Wei ^a   Bover, Laura ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

BST2; Dendritic cell receptors; Dendritic cells; ILT7; Plasmacytoid dendritic cells; Receptor signal

Indexed keywords

BONE MARROW STROMAL CELL ANTIGEN 2; CELL ANTIGEN; CELL RECEPTOR; IMMUNOGLOBULIN LIKE TRANSCRIPT 7; INTERFERON; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

CANCER CELL; DENDRITIC CELL; HUMAN; INNATE IMMUNITY; INTERFERON PRODUCTION; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; VIRUS INFECTION;

ANIMALS; ANTIGENS, CD; DENDRITIC CELLS; HUMANS; IMMUNITY, INNATE; INTERFERON TYPE I; LIGANDS; MEMBRANE GLYCOPROTEINS; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; VIRUS DISEASES;

EID: 77349120712     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.0105-2896.2009.00867.x     Document Type: Review

References (162)

1. Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med 1973 137 : 1142 1162.
2. Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature 2007 449 : 419 426.
3. Steinman RM. Dendritic cells: versatile controllers of the immune system. Nat Med 2007 13 : 1155 1159.
4. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998 392 : 245 252.
5. Colonna M, Trinchieri G, Liu YJ. Plasmacytoid dendritic cells in immunity. Nat Immunol 2004 5 : 1219 1226.
6. Liu Y-J. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 2005 23 : 275 306.
7. Gilliet M, Cao W, Liu Y-J. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol 2008 8 : 594 606.
8. Siegal FP, et al. The nature of the principal type 1 interferon-producing cells in human blood. Science 1999 284 : 1835 1837.
9. Rissoan M-C, et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science 1999 283 : 1183 1186.
10. Cella M, et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med 1999 5 : 919 923.
11. Dzionek A, et al. BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon α/β induction. J Exp Med 2001 194 : 1823 1834.
12. Cao W, et al. Plasmacytoid dendritic cell-specific receptor ILT7-FcεRIγ inhibits Toll-like receptor-induced interferon production. J Exp Med 2006 203 : 1399 1405.
13. Cao W, et al. Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction. J Exp Med 2009 206 : 1603 1614.
14. Robbins S, et al. Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling. Genome Biol 2008 9 : R17.
15. Kumar H, Kawai T, Akira S. Pathogen recognition in the innate immune response. Biochem J 2009 420 : 1 16.
16. Kawai T, Akira S. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol 2009 21 : 317 337.
17. Medzhitov R. Approaching the asymptote: 20 years later. Immunity 2009 30 : 766 775.
18. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004 4 : 499 511.
19. Pasare C, Medzhitov R. Toll-like receptors: linking innate and adaptive immunity. Microbes Infect 2004 6 : 1382 1387.
20. Yoneyama M, Fujita T. Function of RIG-I-like receptors in antiviral innate immunity. J Biol Chem 2007 282 : 15315 15318. (Pubitemid 47093255)
21. Chiu Y-H, MacMillan JB, Chen ZJ. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 2009 138 : 576 591.
22. Schroder K, Muruve DA, Tschopp J. Innate immunity: cytoplasmic DNA sensing by the AIM2 inflammasome. Curr Biol 2009 19 : R262 R265.
23. Kadowaki N, et al. Subsets of human dendritic cell precursors express different Toll-like receptors and respond to different microbial antigens. J Exp Med 2001 194 : 863 870.
24. Hornung V, et al. Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 2002 168 : 4531 4537.
25. Jarrossay D, Napolitani G, Colonna M, Sallusto F, Lanzavecchia A. Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur J Immunol 2001 31 : 3388 3393.
26. Lund JM, et al. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci USA 2004 101 : 5598 5603.
27. Heil F, et al. Species-specific recognition of single-stranded RNA via Toll-like receptor 7 and 8. Science 2004 303 : 1526 1529.
28. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004 303 : 1529 1531. (Pubitemid 38314425)
29. Bauer S, et al. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci USA 2001 98 : 9237 9242.
30. Hemmi H, et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000 408 : 740 745.
31. Haas T, et al. The DNA sugar backbone 2′ deoxyribose determines Toll-like receptor 9 activation. Immunity 2008 28 : 315 323.
32. Wagner H. The immunobiology of the TLR9 subfamily. Trends Immunol 2004 25 : 381 386.
33. Park B, Brinkmann MM, Spooner E, Lee CC, Kim Y-M, Ploegh HL. Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9. Nat Immunol 2008 9 : 1407 1414.
34. Ewald SE, et al. The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor. Nature 2008 456 : 658 662.
35. Kawai T, et al. Interferon-α induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol 2004 5 : 1061 1068.
36. Honda K, et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 2005 434 : 772 777.
37. Honda K, Taniguchi T. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 2006 6 : 644 658.
38. Cisse B, et al. Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell 2008 135 : 37 48.
39. Colina R, et al. Translational control of the innate immune response through IRF-7. Nature 2008 452 : 323 328.
40. Tailor P, et al. The feedback phase of type I interferon induction in dendritic cells requires interferon regulatory factor 8. Immunity 2007 27 : 228 239.
41. Tsujimura H, Tamura T, Ozato K. Cutting edge: IFN consensus sequence binding protein/IFN regulatory factor 8 drives the development of type I IFN-producing plasmacytoid dendritic cells. J Immunol 2003 170 : 1131 1135.
42. Kumagai Y, Kumar H, Koyama S, Kawai T, Takeuchi O, Akira S. Cutting edge: TLR-dependent viral recognition along with type I IFN positive feedback signaling masks the requirement of viral replication for IFN-α production in plasmacytoid dendritic cells. J Immunol 2009 182 : 3960 3964.
43. Watarai H, Sekine E, Inoue S, Nakagawa R, Kaisho T, Taniguchi M. PDC-TREM, a plasmacytoid dendritic cell-specific receptor, is responsible for augmented production of type I interferon. Proc Nat Acad Sci USA 2008 105 : 2993 2998.
44. Grouard G, Rissoan M-C, Filgueira L, Durand I, Banchereau J, Liu Y-J. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J Exp Med 1997 185 : 1101 1112.
45. Latz E, et al. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol 2004 5 : 190 198.
46. Honda K, et al. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 2005 434 : 1035 1040.
47. Guiducci C, et al. Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation. J Exp Med 2006 203 : 1999 2008.
48. Barton GM, Kagan JC, Medzhitov R. Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immunol 2006 7 : 49 56.
49. Casrouge A, et al. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 2006 314 : 308 312.
50. Tabeta K, et al. The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9. Nat Immunol 2006 7 : 156 164.
51. Brinkmann MM, Spooner E, Hoebe K, Beutler B, Ploegh HL, Kim Y-M. The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling. J Cell Biol 2007 177 : 265 275.
52. Yang Y, et al. Heat shock protein gp96 is a master chaperone for Toll-like receptors and is important in the innate function of macrophages. Immunity 2007 26 : 215 226.
53. Brown D, Trowsdale J, Allen R. The LILR family: modulators of innate and adaptive immune pathways in health and disease. Tissue Antigens 2004 64 : 215 225.
54. Anderson KJ, Allen RL. Regulation of T-cell immunity by leucocyte immunoglobulin-like receptors: innate immune receptors for self on antigen-presenting cells. Immunology 2009 127 : 8 17.
55. Katz HR, Frederick WA. Inhibition of inflammatory responses by leukocyte Ig-like receptors. Advances in Immunolology. Academic Press, 2006 91 : 251 272.
56. Canavez F, et al. Comparison of chimpanzee and human leukocyte Ig-like receptor genes reveals framework and rapidly evolving genes. J Immunol 2001 167 : 5786 5794.
57. Humphrey M, Lanier L, Nakamura M. Role of ITAM-containing adapter proteins and their receptors in the immune system and bone. Immunol Rev 2005 208 : 50 65.
58. Reth M. Antigen receptor tail clue. Nature 1989 338 : 383 384.
59. Barrow AD, Trowsdale J. You say ITAM and I say ITIM, let's call the whole thing off: the ambiguity of immunoreceptor signalling. Eur J Immnol 2006 36 : 1646 1653.
60. Ravetch JV, Lanier LL. Immune inhibitory receptors. Science 2000 290 : 84 89.
61. Cosman D, et al. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 1997 7 : 273 282.
62. Chapman TL, Heikema AP, Bjorkman PJ. The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. Immunity 1999 11 : 603 613.
63. Lichterfeld M, et al. A viral CTL escape mutation leading to immunoglobulin-like transcript 4 mediated functional inhibition of myelomonocytic cells. J Exp Med 2007 204 : 2813 2824.
64. Nakayama M, et al. Paired Ig-like receptors bind to bacteria and shape TLR-mediated cytokine production. J Immunol 2007 178 : 4250 4259.
65. Young NT, Waller ECP, Patel R, Roghanian A, Austyn JM, Trowsdale J. The inhibitory receptor LILRB1 modulates the differentiation and regulatory potential of human dendritic cells. Blood 2008 111 : 3090 3096.
66. Wagner CS, Walther-Jallow L, Buentke E, Ljunggren H-G, Achour A, Chambers BJ. Human cytomegalovirus-derived protein UL18 alters the phenotype and function of monocyte-derived dendritic cells. J Leukoc Biol 2008 83 : 56 63.
67. Chang CC, et al. Tolerization of dendritic cells by TS cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol 2002 3 : 237 243.
68. Vladimir R, Siyuan L, Wei Z, Juan W, Anatolij H. Tolerization of dendritic cells by HLA-G. Eur J Imm 2005 35 : 1133 1142.
69. Allen RL, Raine T, Haude A, Trowsdale J, Wilson MJ. Cutting edge: leukocyte receptor complex-encoded immunomodulatory receptors show differing specificity for alternative HLA-B27 structures. J Immunol 2001 167 : 5543 5547.
70. Shiroishi M, Kajikawa M, Kuroki K, Ose T, Kohda D, Maenaka K. Crystal structure of the human monocyte-activating receptor, "Group 2" leukocyte Ig-like receptor A5 (LILRA5/LIR9/ILT11). J Biol Chem 2006 281 : 19536 19544. (Pubitemid 44035457)
71. Nakajima H, Samaridis J, Angman L, Colonna M. Cutting edge: human myeloid cells express an activating ilt receptor (ILT1) that associates with Fc receptor γ-chain. J Immunol 1999 162 : 5 8.
72. Lee DJ, et al. LILRA2 activation inhibits dendritic cell differentiation and antigen presentation to T cells. J Immunol 2007 179 : 8128 8136.
73. Borges L, Kubin M, Kuhlman T. LIR9, an immunoglobulin-superfamily- activating receptor, is expressed as a transmembrane and as a secreted molecule. Blood 2003 101 : 1484 1486.
74. Bleharski JR, et al. Use of genetic profiling in leprosy to discriminate clinical forms of the disease. Science 2003 301 : 1527 1530.
75. Rissoan MC, et al. Subtractive hybridization reveals the expression of immunoglobulin-like transcript 7, Eph-B1, granzyme B, and 3 novel transcripts in human plasmacytoid dendritic cells. Blood 2002 100 : 3295 3303.
76. Cho M, et al. SAGE library screening reveals ILT7 as a specific plasmacytoid dendritic cell marker that regulates type I IFN production. Int Immunol 2008 20 : 155 164.
77. Ju X-S, et al. Immunoglobulin-like transcripts ILT2, ILT3 and ILT7 are expressed by human dendritic cells and down-regulated following activation. Gene 2004 331 : 159 164.
78. Nakajima H, et al. Transcriptional regulation of ILT family receptors. J Immunol 2003 171 : 6611 6620.
79. Lanier LL. Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol 2008 9 : 495 502.
80. Ivashkiv LB. Cross-regulation of signaling by ITAM-associated receptors. Nat Immunol 2009 10 : 340 347.
81. Lanier LL. DAP10- and DAP12-associated receptors in innate immunity. Immunol Rev 2009 227 : 150 160.
82. Humphrey MB, Lanier LL, Nakamura MC. Role of ITAM-containing adapter proteins and their receptors in the immune system and bone. Immunol Rev 2005 208 : 50 65.
83. Shigematsu H, et al. Plasmacytoid dendritic cells activate lymphoid-specific genetic programs irrespective of their cellular origin. Immunity 2004 21 : 43 53.
84. Pelayo R, et al. Derivation of 2 categories of plasmacytoid dendritic cells in murine bone marrow. Blood 2005 105 : 4407 4415.
85. Corcoran L, et al. The lymphoid past of mouse plasmacytoid cells and thymic dendritic cells. J Immunol 2003 170 : 4926 4932.
86. Jun JE, Goodnow CC. Scaffolding of antigen receptors for immunogenic versus tolerogenic signaling. Nat Immunol 2003 4 : 1057 1064.
87. Koretzky GA, Abtahian F, Silverman MA. SLP76 and SLP65: complex regulation of signalling in lymphocytes and beyond. Nat Rev Immunol 2006 6 : 67 78.
88. Cao W, et al. BDCA2/FcεRIγ complex signals through a novel BCR-like pathway in human plasmacytoid dendritic cells. PLoS Biol 2007 5 : e248.
89. Röck J, et al. CD303 (BDCA-2) signals in plasmacytoid dendritic cells via a BCR-like signalosome involving Syk, Slp65 and PLCγ2. Eur J Immunol 2007 37 : 3564 3575.
90. Kupzig S. Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology. Traffic 2003 4 : 694 709.
91. Ohtomo T, et al. Molecular cloning and characterization of a surface antigen preferentially overexpressed on multiple myeloma cells. Biochem Biophys Res Comm 1999 258 : 583 591.
92. Walter-Yohrling J, et al. Identification of genes expressed in malignant cells that promote invasion. Cancer Res 2003 63 : 8939 8947.
93. Masuyama N, et al. HM1.24 is internalized from lipid rafts by clathrin-mediated endocytosis through interaction with α-adaptin. J Biol Chem 2009 284 : 15927 15941.
94. Ishikawa J, et al. Molecular cloning and chromosomal mapping of a bone marrow stromal cell surface gene, BST2, that may be involved in pre-B-cell growth. Genomics 1995 26 : 527 534.
95. Cai D, et al. Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis. BMC Cancer 2009 9 : 102.
96. Neil SJD, Zang T, Bieniasz PD. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 2008 451 : 425 430.
97. Van Damme N, et al. The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 2008 3 : 245 252.
98. Blasius AL, Giurisato E, Cella M, Schreiber RD, Shaw AS, Colonna M. Bone marrow stromal cell antigen 2 is a specific marker of type I IFN-producing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation. J Immunol 2006 177 : 3260 3265.
99. Ge Y, et al. Differential gene expression, GATA1 target genes, and the chemotherapy sensitivity of Down syndrome megakaryocytic leukemia. Blood 2006 107 : 1570 1581.
100. Shiroishi M, et al. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc Natl Acad Sci USA 2003 100 : 8856 8861.
101. Kamphuis E, Junt T, Waibler Z, Forster R, Kalinke U. Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia. Blood 2006 108 : 3253 3261.
102. Lin Q, Dong C, Cooper MD. Impairment of T and B cell development by treatment with a type I interferon. J Exp Med 1998 187 : 79 87.
103. Passegue E, Ernst P. IFN-α wakes up sleeping hematopoietic stem cells. Nat Med 2009 15 : 612 613.
104. Gota C, Calabrese L. Induction of clinical autoimmune disease by therapeutic interferon-alpha. Autoimmunity 2003 36 : 511 518.
105. Yamada E, McVicar D. Paired receptor systems of the innate immune system. Curr Protoc Immunol 2008 81 : A.1x.1 A.1x.25.
106. Karlhofer FM, Ribaudo RK, Yokoyama WM. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells. Nature 1992 358 : 66 70.
107. Arase H, Mocarski ES, Campbell AE, Hill AB, Lanier LL. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 2002 296 : 1323 1326.
108. Smith HRC, et al. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Nat Acad Sci USA 2002 99 : 8826 8831.
109. Desrosiers M-P, et al. Epistasis between mouse Klra and major histocompatibility complex class I loci is associated with a new mechanism of natural killer cell-mediated innate resistance to cytomegalovirus infection. Nat Genet 2005 37 : 593 599.
110. Diefenbach A, Jensen ER, Jamieson AM, Raulet DH. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature 2001 413 : 165 171.
111. Cerwenka A, et al. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 2000 12 : 721 727.
112. Carayannopoulos LN, Naidenko OV, Fremont DH, Yokoyama WM. Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D. J Immunol 2002 169 : 4079 4083.
113. Diefenbach A, Hsia Jennifer K, Hsiung M-Yu B, Raulet David H. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity. Eur J Immunol 2003 33 : 381 391.
114. Hamerman JA, Ogasawara K, Lanier LL. Cutting edge: toll-like receptor signaling in macrophages induces ligands for the NKG2D receptor. J Immunol 2004 172 : 2001 2005.
115. Lodoen M, et al. NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. J Exp Med 2003 197 : 1245 1253.
116. Nice TJ, Coscoy L, Raulet DH. Posttranslational regulation of the NKG2D ligand Mult1 in response to cell stress. J Exp Med 2009 206 : 287 298.
117. Bauer S, et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999 285 : 727 729.
118. Cosman D, et al. ULBPs, novel MHC class I related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 2001 14 : 123 133.
119. Chalupny J, Sutherland CL, Lawrence WA, Rein-Weston A, Cosman D. ULBP4 is a novel ligand for human NKG2D. Biochem Biophy Res Comm 2003 305 : 129 135.
120. Ebihara T, et al. Induction of NKG2D ligands on human dendritic cells by TLR ligand stimulation and RNA virus infection. Int Immunol 2007 19 : 1145 1155.
121. Treilleux I, et al. Dendritic cell infiltration and prognosis of early stage breast cancer. Clin Cancer Res 2004 10 : 7466 7474.
122. Benitez-Ribas D, et al. Plasmacytoid dendritic cells of melanoma patients present exogenous proteins to CD4+ T cells after FcγRII-mediated uptake. J Exp Med 2006 203 : 1629 1635.
123. Salio M, et al. Plasmacytoid dendritic cells prime IFN-γ-secreting melanoma-specific CD8 lymphocytes and are found in primary melanoma lesions. Eur J Immunol 2003 33 : 1052 1062.
124. Wei S, et al. Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma. Cancer Res 2005 65 : 5020 5026.
125. Zou W, et al. Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat Med 2001 7 : 1339 1346.
126. Della Bella S, et al. Quantitative and functional defects of dendritic cells in classic Kaposi's sarcoma. Clin Immunol 2006 119 : 317 329.
127. Mohty M, et al. Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment. Blood 2001 98 : 3750 3756.
128. Mohty M, Olive D, Gaugler B. Plasmacytoid DCs and cancer: a new role for an enigmatic cell. Trends Immunol 2004 25 : 397 398.
129. Hartmann E, et al. Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer. Cancer Res 2003 63 : 6478 6487.
130. Sisirak V, et al., eds. Breast tumor environment inhibits human plasmacytoid dendritic cells functions. The 10th International Symposium on Dendritic Cells 2008 : P-4-03.
131. Wenzel J, Bekisch B, Uerlich M, Haller O, Bieber T, Tuting T. Type I interferon-associated recruitment of cytotoxic lymphocytes: a common mechanism in regressive melanocytic lesions. Am J Clin Pathol 2005 124 : 37 48.
132. Dunn GP, Koebel CM, Schreiber RD. Interferons, immunity and cancer immunoediting. Nat Rev Immunol 2006 6 : 836 848.
133. Matsuda A, et al. Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways. Oncogene 2003 22 : 3307 3318.
134. Masuda A, Nakamura A, Maeda T, Sakamoto Y, Takai T. Cis binding between inhibitory receptors and MHC class I can regulate mast cell activation. J Exp Med 2007 204 : 907 920.
135. Dahl ME, Dabbagh K, Liggitt D, Kim S, Lewis DB. Viral-induced T helper type 1 responses enhance allergic disease by effects on lung dendritic cells. Nat Immunol 2004 5 : 337 343.
136. Chalifour A, et al. A role for cis interaction between the inhibitory Ly49A receptor and MHC Class I for natural killer cell education. Immunity 2009 30 : 337 347.
137. Lande R, et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 2007 449 : 564 569.
138. Blanco P, Palucka AK, Gill M, Pascual V, Banchereau J. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 2001 294 : 1540 1543.
139. Marshak-Rothstein A, Rifkin IR. Immunologically active autoantigens: the role of Toll-like receptors in the development of chronic inflammatory disease. Annu Rev Immunol 2007 25 : 419 441.
140. Tian J, et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 2007 8 : 487 496.
141. Vollmer J, et al. Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8. J Exp Med 2005 202 : 1575 1585.
142. Savarese E, et al. U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7. Blood 2006 107 : 3229 3234.
143. Yasuda K, et al. Endosomal translocation of vertebrate DNA activates dendritic cells via TLR9-dependent and -independent pathways. J Immunol 2005 174 : 6129 6136.
144. Cao W. Molecular characterization of human plasmacytoid dendritic cells. J Clin Immunol 2009 29 : 257 264.
145. Martinelli E, et al. HIV-1 gp120 inhibits TLR9-mediated activation and IFN-α secretion in plasmacytoid dendritic cells. Proc Natl Acad Sci USA 2007 104 : 3396 3401.
146. Xu Y, et al. HBsAg inhibits TLR9-mediated activation and IFN-α production in plasmacytoid dendritic cells. Mol Immunol 2009 46 : 2640 2646.
147. Novak N, et al. Characterization of FcεRI-bearing CD123+ blood dendritic cell antigen-2+ plasmacytoid dendritic cells in atopic dermatitis. J Allergy Clin Immunol 2004 114 : 364 370.
148. Fuchs A, Cella M, Kondo T, Colonna M. Paradoxic inhibition of human natural interferon-producing cells by the activating receptor NKp44. Blood 2005 106 : 2076 2082.
149. Schroeder JT, et al. TLR9- and FcεRI-mediated responses oppose one another in plasmacytoid dendritic cells by down-regulating receptor expression. J Immunol 2005 175 : 5724 5731.
150. Green DS, Lum T, Green JA. IgG-derived Fc down-regulates virus-induced plasmacytoid dendritic cell (pDC) IFNα production. Cytokine 2004 26 : 209 216.
151. Blasius AL, Cella M, Maldonado J, Takai T, Colonna M. Siglec-H is an IPC-specific receptor that modulates type I IFN secretion through DAP12. Blood 2006 107 : 2474 2476.
152. Blasius A, Vermi W, Krug A, Facchetti F, Cella M, Colonna M. A cell-surface molecule selectively expressed on murine natural interferon-producing cells that blocks secretion of interferon-alpha. Blood 2004 103 : 4201 4206.
153. Sjolin H, et al. DAP12 signaling regulates plasmacytoid dendritic cell homeostasis and down-modulates their function during viral infection. J Immunol 2006 177 : 2908 2916.
154. Kamogawa-Schifter Y, Ohkawa J, Namiki S, Arai N, Arai K-i, Liu Y. Ly49Q defines 2 pDC subsets in mice. Blood 2005 105 : 2787 2792.
155. Tai L-H, et al. Recognition of H-2Kb by Ly49Q suggests a role for class Ia MHC regulation of plasmacytoid dendritic cell function. Mol Immunol 2007 44 : 2638 2646.
156. Tai L-H, et al. Positive regulation of plasmacytoid dendritic cell function via Ly49Q recognition of class I MHC. J Exp Med 2008 205 : 3187 3199.
157. Ju X, Zenke M, Hart DNJ, Clark GJ. CD300a/c regulate type I interferon and TNF-α secretion by human plasmacytoid dendritic cells stimulated with TLR7 and TLR9 ligands. Blood 2008 112 : 1184 1194.
158. Ochando JC, et al. Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat Immunol 2006 7 : 652 662.
159. de Heer HJ, et al. Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J Exp Med 2004 200 : 89 98.
160. Goubier A, et al. Plasmacytoid dendritic cells mediate oral tolerance. Immunity 2008 29 : 464 475.
161. Palucka AK, Hideki U, Joseph WF, Jacques B. Taming cancer by inducing immunity via dendritic cells. Immunol Rev 2007 220 : 129 150.
162. Rosen DB, et al. Functional consequences of interactions between human NKR-P1A and its ligand LLT1 expressed on activated dendritic cells and B cells. J Immunol 2008 180 : 6508 6517.